NASDAQ:SNWV • US80303D3052
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SANUWAVE HEALTH INC (SNWV).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-09-03 | Northland Capital Markets | Initiate | Outperform |
| 2025-08-22 | Roth Capital | Maintains | Buy -> Buy |
| 2025-07-29 | Roth Capital | Initiate | Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 16.742M 28.69% | 20.398M 21.84% | 32.634M 59.99% | 45.062M 38.08% | 59.109M 31.17% | 78.407M 32.65% | |
| EBITDA YoY % growth | -8M 38.01% | 488K 106.10% | 6.562M 1,244.67% | 13.566M 106.74% | 18.666M 37.59% | 25.66M 37.47% | |
| EBIT YoY % growth | -8.952M 36.70% | -540K 93.97% | 5.417M 1,103.15% | 6.412M 18.37% | 10.392M 62.07% | 18.255M 75.66% | |
| Operating Margin | -53.47% | -2.65% | 16.60% | 14.23% | 17.58% | 23.28% | |
| EPS YoY % growth | N/A | N/A | N/A | 0.43 | 0.95 120.00% | 1.92 101.07% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.17 114.33% | 0.08 | 0.18 1,746.20% | 0.35 44.50% | 0.37 111.76% | 0.37 351.25% | 0.46 146.96% | 0.63 81.76% | 0.79 116.39% |
| Revenue Q2Q % growth | 13.515M 30.83% | 11.322M 21.19% | 13.26M 30.46% | 16.524M 44.30% | 21.42M 58.49% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 4.182M 14.04% | 2.958M 134.76% | 3.876M 58.20% | 5.304M 152.45% | 6.324M 51.22% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 1.995M -20.90% | 1.118M 13.39% | 1.991M 6.07% | 3.492M 138.04% | N/A | N/A | N/A | N/A | N/A |
All data in USD
8 analysts have analysed SNWV and the average price target is 55.08 USD. This implies a price increase of 143.93% is expected in the next year compared to the current price of 22.58.
SANUWAVE HEALTH INC (SNWV) will report earnings on 2026-03-19.
The consensus EPS estimate for the next earnings of SANUWAVE HEALTH INC (SNWV) is 0.17 USD and the consensus revenue estimate is 13.52M USD.
The number of analysts covering SANUWAVE HEALTH INC (SNWV) is 8.